Combining the skills of the LYSARC dedicated team, including five Project Managers, and the LYSA experts center network. The latter includes early-phase centers (“CLIP2″) accredited by the French NCI.
This platform for the realization of phase I/IIa clinical trials conducts studies, including first-in man trials, in cooperation with industry. Eight to twelve LYSA centers are available for phase I trials and twenty to thirty LYSA centers for phase IIa trials. This platform, which activity increases rapidly, received in 2011 support from the French Ligue Against Cancer .